The global western blotting market is expected to grow at a CAGR of 6.7 percent to USD 1.4 billion by 2026, up from USD 1.0 billion in 2021. The primary factors driving market expansion include technological advancements, increased government financing in the field of biomedical research, a rising desire for personalized treatment, and the rising prevalence of HIV.
Western Blotting Market, often known as immunoblotting, is a blotting technique for separating and identifying proteins. Tissue preparation, gel electrophoresis, transfer of proteins onto the membrane, blocking to prevent membrane and antibody interactions, incubation of membrane, and antibody-based detection of proteins are all phases in western blotting.
Drivers of the Western Blotting Market in the World
Over the forecast period, the worldwide western blotting market is expected to rise due to the rising prevalence of HIV/AIDS. For example, the Joint United Nations Program on HIV/AIDS estimates that 37.9 million individuals worldwide were living with HIV at the end of 2018.
Furthermore, rising applications of the western blotting technique are likely to drive market expansion. In January 2020, researchers from the British Antarctic Survey and the Natural Environment Research Council in the United Kingdom reported using western blotting to analyze post-translationally deiminated protein and EV profiles of plasma in Antarctic seabird species.
Restraints in the Global Western Blotting Market
The emergence of alternative technologies is projected to stifle market expansion. AlphaScreen technology, for example, is a new and very sensitive homogeneous bead-based platform for the identification of biomolecules. The method eliminates the need for time-consuming wash procedures and detects any molecule of interest, primarily from protein complexes.
Opportunities in the Global Western Blotting Market
Better imaging software for managing western blotting findings is predicted to provide lucrative growth prospects for global western blotting market participants. With the increased usage of western blotting, a great amount of data is generated, which must be saved, processed, and evaluated. Scanning film-based results and generating albums with photo management software allows for space savings, random access, result backup, and quick result sharing.
The Competitive Landscape of the Global Western Blotting Market
Thermo Fisher Scientific, Inc., GE Healthcare, Hoffmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), Bio-Techne Corporation (ProteinSimple Inc.)
0 Comments